Azithromycin: Antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys

Experimental Parasitology

Volumn 94, Issue 1, 2000, Pages 8-14

  Puri, S K ^a   Singh, Naresh ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLOROQUINE; DOXYCYCLINE; ERYTHROMYCIN; PRIMAQUINE; PYRIMETHAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; FEMALE; MALARIA; MALE; MOUSE; NONHUMAN; PLASMODIUM CYNOMOLGI; PLASMODIUM YOELII; PRIORITY JOURNAL; PROPHYLAXIS; RHESUS MONKEY;

ANIMALIA; MACACA MULATTA; PLASMODIUM CYNOMOLGI; PLASMODIUM YOELII; PROTOZOA; RODENTIA; SIMIAE;

EID: 0033973112     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1999.4465     Document Type: Article

References (25)

1. Andersen S. L., Ager A. L., Greevy P. Mc., Schuster B. G., Ellis W., Berman J. Efficacy of azithromycin as a causal prophylactic agent against murine malaria. Antimicrobial Agents Chemotherapy. 38:1994;1862-1863.
2. Andersen S. L., Ager A., Greevy P. Mc., Schuster B. G., Wesche D., Kuschner R., Ohrt C., Ellis W., Rossan R., Berman J. Activity of azithromycin as a blood schizontocide against rodent and human. Plasmodia in vivo. American Journal of Tropical Medicine and Hygiene. 52:1995;159-161.
3. Araujo F. G, Guptill D. R., Remington J. S. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrobial Agents Chemotherapy. 32:1988;755-757.
4. Bray R. S., Burgess R. W., Fox R. M., Miller M. J. Effect of pyrimethamine upon sporogony and pre-erythrocytic schizogony of Laverania falciparum. Bulletin of the World Health Organization. 21:1959;233-238.
5. Bray R. S. The response of Plasmodium vivax to antifols. Trans actions of the Royal Society of Tropical Medicine and Hygiene. 78:1984;420-421.
6. Duarte E. C., Fontes C.J. F., Gyorkos T. W., Abrahamowicz M. Randomized controlled trial of artesunate plus tetracycline versus standard treatment (quinine plus tetracycline) for uncomplicated Plasmodium falciparum malaria in Brazil. American Journal of Tropical Medicine and Hygiene. 54:1996;197-202.
7. Dunn C. J., Barradell L. B. Azithromycin: A review of its pharmacological properties and use as 3 day therapy in respiratory tract infections. Drugs. 51:1996;483-505.
8. Dutta G. P., Puri S. K. Standardization of Plasmodium cynomolgi B-rhesus monkey model for radical curative test and primaquine sensitivity of the relapse stages of the parasite from different cyclic passage. Indian Journal of Parasitology. 12:1988;109-115.
9. Eyles D. E., Coatney G. R. Effect of certain drugs on exoerythrocytic parasites of Plasmodium cynomolgi. American Journal of Tropical Medicine and Hygiene. 11:1962;175-185.
10. Gingras B. A., Jensen J. B. Activity of azithromycin (CP-62993) and erythromycin against chloroquine sensitive and chloroquine resistant strains of Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene. 47:1992;378-383.
11. Gingras B. A., Jensen J. B. Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. American Journal of Tropical Medicine and Hygiene. 94:1993;101-105.
12. Hill J. The activity of some antibiotics and long acting compounds against the tissue stages of Plasmodium berghei. Annals of Tropical Medicine and Parasitology. 69:1975;421-427.
13. Looareesuwan S., Viravan C., Vanijanonta S., Wilairatana P., Charoenlarp P., Canfield C. J., Kyle D. E. Randomized trial of mefloquine-doxycycline and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene. 50, 1994;784-789.
14. Pang L. W., Boudreau E. F., Childs G. E., Webster H. K., Supanantalerk C., Somutsakorn P. Failure of large-dose erythromycin in combination with a standard dose of chloroquine or quinine in the treatment of human falciparum malaria. Bulletin of the World Health Organization. 63:1985;739-743.
15. Peters W., Davies E. E., Robinson B. L. The chemotherapy of rodent malaria, XXIII. Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening. Annals of Tropical Medicine and Parasitology. 69:1975;311-328.
16. Puri S. K., Dutta G. P. Antibiotics in the chemotherapy of malaria. Progress in Drug Research. 26:1982;167-205.
17. Puri S. K., Dutta G. P. Spectrum of the antimalarial activity of a new macrolide antibiotic midecamycin in mice and monkeys. Chemotherapy. 35:1989;187-197.
18. Puri S. K., Kamboj K. K., Dutta G. P. Infectivity studies on Anopheles stephensi using P. cynomolgi B infection in rhesus monkeys. Tropical Medicine and Parasitology. 40:1989;409-411.
19. Schmidt L. H. Appraisals of compounds of diverse chemical classes for capacities to cure infections with sporozoites of Plasmodium cynomolgi. American Journal of Tropical Medicine and Hygiene. 32:1983;231-257.
20. Singh N., Puri S. K. Causal prophylactic activity of antihis taminic agents against Plasmodium yoelii nigeriensis infection in Swiss mice. Acta Tropica. 69:1998;255-260.
21. Strath M., Finnigan T. S., Gardner M., Williamson D., Wilson I. Antimalarial activity of rifampicin in vitro and in rodent models. Transactions of the Royal Society of Tropical Medicine and Hygiene. 87:1993;211-216.
22. Watt G. L., Loesuttivibool L., Shanks G. D., Boudreau E. F., Brown A. F., Pavanand K., Webster H. K., Wechgritaya S. Quinine with tetracycline for the treatment of drug resistant falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene. 47:1992;108-111.
23. White N. J., Olliaro P. L. Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria. Parasitology Today. 12:1996;399-401.
24. World Health Organization Technical Report. 1984.
25. World Health Organization. 1995. "The World Health Report." World Health Organization, Geneva.